Drug Indications

#	Molecule Aladdin ID	Parent Molecule Name	Parent Molecule Type	Max Phase for Indication	First Approval	MESH ID	MESH Heading	EFO IDs	EFO Terms	References
1.	ALA33	LEVOFLOXACIN ANHYDROUS	Small molecule	2.0	1996	D009369	Neoplasms	MONDO:0004992	cancer	ALA5315124(Alt. Form) ClinicalTrials: [1]
2.	ALA5315048	ZILUCOPLAN SODIUM	Protein	4.0	2023	D009157	Myasthenia Gravis	EFO:0004991	Myasthenia gravis	ALA5315048(Parent) FDA: [1]
3.	ALA5314650	TECHNETIUM TC-99M LABELED CARBON	Unknown	4.0	2023	D003952	Diagnostic Imaging	CHEBI:33295	diagnostic agent	ALA5314650(Parent) FDA: [1]
4.	ALA4085457	RITLECITINIB	Small molecule	4.0	2023	D000506	Alopecia Areata	EFO:0004192	alopecia areata	ALA5314649(Alt. Form) FDA: [1]
5.	ALA5314898	ZALOGANAN	Protein	2.0		D001424	Bacterial Infections	EFO:0000771	bacterial disease	ALA5314898(Parent) INN: [1]
6.	ALA5314896	XIRESTOMIG	Antibody	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314896(Parent) INN: [1]
7.	ALA5314894	VILASTOBART	Antibody	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314894(Parent) INN: [1]
8.	ALA5314892	VEVOCTADEKIN	Protein	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314892(Parent) INN: [1]
9.	ALA5314890	UPREVSTOBART	Antibody	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314890(Parent) INN: [1]
10.	ALA5314889	UCASAREOTIDE DASAROXETAN	Protein	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314889(Parent) INN: [1]
11.	ALA5314888	TROCULEUCEL	Cell	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314888(Parent) INN: [1]
12.	ALA5314887	TRAXIVITUG	Antibody	2.0		D014777	Virus Diseases	EFO:0000763	viral disease	ALA5314887(Parent) INN: [1]
13.	ALA5314886	TRASTUZUMAB BRENGITECAN	Antibody drug conjugate	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314886(Parent) INN: [1]
14.	ALA5314883	SUCANTOMOTIDE	Protein	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314883(Parent) INN: [1]
15.	ALA5314882	SOLRIKITUG	Antibody	2.0		D007249	Inflammation	MP:0001845	inflammation	ALA5314882(Parent) INN: [1]
16.	ALA5314880	SILEVIMIG	Protein	2.0		D014777	Virus Diseases	EFO:0000763	viral disease	ALA5314880(Parent) INN: [1]
17.	ALA5314879	SIGVOTATUG VEDOTIN	Antibody drug conjugate	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314879(Parent) INN: [1]
18.	ALA5314878	SIGVOTATUG	Antibody	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314878(Parent) INN: [1]
19.	ALA5314876	SENIPRUTUG	Antibody	2.0		D001327	Autoimmune Diseases	EFO:0005809	type II hypersensitivity reaction disease	ALA5314876(Parent) INN: [1]
20.	ALA5314875	SACITUZUMAB TIRUMOTECAN	Antibody drug conjugate	2.0		D009369	Neoplasms	EFO:0000616	neoplasm	ALA5314875(Parent) INN: [1]